N-((1S,5R,6s)-3-benzyl-3-aza-bicyclo[3.1.0]hexan-6-yl)-2-hydroxy-2-phenylacetamide

ID: ALA248616

Chembl Id: CHEMBL248616

PubChem CID: 44443726

Max Phase: Preclinical

Molecular Formula: C20H22N2O2

Molecular Weight: 322.41

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(N[C@H]1[C@@H]2CN(Cc3ccccc3)C[C@@H]21)C(O)c1ccccc1

Standard InChI:  InChI=1S/C20H22N2O2/c23-19(15-9-5-2-6-10-15)20(24)21-18-16-12-22(13-17(16)18)11-14-7-3-1-4-8-14/h1-10,16-19,23H,11-13H2,(H,21,24)/t16-,17+,18+,19?

Standard InChI Key:  UGNOTWMFRTUFBZ-ULNPTZJRSA-N

Associated Targets(non-human)

Chrm2 Muscarinic acetylcholine receptor M2 (1011 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrm3 Muscarinic receptor M2 and M3 (126 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrm3 Muscarinic acetylcholine receptor M3 (655 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 322.41Molecular Weight (Monoisotopic): 322.1681AlogP: 1.97#Rotatable Bonds: 5
Polar Surface Area: 52.57Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.46CX Basic pKa: 8.63CX LogP: 1.67CX LogD: 0.42
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.88Np Likeness Score: -0.41

References

1. Kumar N, Kaur K, Aeron S, Dharmarajan S, Silamkoti AD, Mehta A, Gupta S, Chugh A, Gupta JB, Salman M, Palle VP, Cliffe IA..  (2007)  Synthesis and optimization of novel and selective muscarinic M(3) receptor antagonists.,  17  (18): [PMID:17629699] [10.1016/j.bmcl.2007.06.081]

Source